Quayside Pharmacy Limited

POWER SEARCH PRICING

SOLUTIONS

quayside pharmacy limited Company Information

Live

MatureSmallDeclining

Company Number

02710642

Next Accounts

Jun 2025

Industry

Other human health activities

Directors

Sunita Jassal

Arun Jassal

Shareholders

mrs sunita jassal

mr arun kumar jassal

Group Structure

View All

Contact

Registered Address

crawhall road, newcastle upon tyne, tyne & wear, NE1 2BL

Website

www.quayside-pharmacy.co.uk

quayside pharmacy limited Estimated Valuation

£4.4m

Pomanda estimates the enterprise value of QUAYSIDE PHARMACY LIMITED at £4.4m based on Net Assets of £1.8m and 2.49x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Quayside Pharmacy Limited is a live company located in tyne & wear, NE1 2BL with a Companies House number of 02710642. It operates in the other human health activities sector, SIC Code 86900. Founded in April 1992, it's largest shareholder is mrs sunita jassal with a 60% stake. Quayside Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.4m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Quayside Pharmacy Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

4 Strong

4 Regular

3 Weak

Size

annual sales of £2.4m, make it larger than the average company (£668.6k)

Growth

3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (5.9%)

EXPORT

Quayside Pharmacy Limited's latest turnover from September 2023 is estimated at £2.4 million and the company has net assets of £1.8 million. According to their latest financial statements, Quayside Pharmacy Limited has 32 employees and maintains cash reserves of £419.4 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	2,387,147	2,962,268	5,669,606	3,804,288	3,533,259	3,060,989	2,375,445	2,238,256	6,066,316	5,652,440	6,227,216	4,479,220	3,203,199	4,066,548	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,474,250	1,856,633	3,752,284	2,441,231	2,260,320	1,982,267	1,469,831	1,382,920	3,802,849	3,524,913	3,809,489	2,599,897	1,849,819	2,286,652	0
Gross Profit	912,897	1,105,635	1,917,321	1,363,058	1,272,939	1,078,722	905,614	855,336	2,263,467	2,127,526	2,417,727	1,879,323	1,353,380	1,779,896	0
Admin Expenses	787,483	1,004,053	1,640,582	1,153,601	1,109,947	1,013,517	804,017	770,094	2,188,010	1,899,938	2,375,817	1,861,987	1,421,652	1,662,339	-733,189
Operating Profit	125,414	101,582	276,739	209,457	162,992	65,205	101,597	85,242	75,457	227,588	41,910	17,336	-68,272	117,557	733,189
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	22,798	9,194	317	147	184	1,389	896	622	558	275	302	599	993	1,157	504
Pre-Tax Profit	148,212	110,777	277,056	209,604	163,177	66,594	102,493	85,864	76,015	227,863	42,212	17,936	-67,279	118,714	733,693
Tax	-37,053	-21,048	-52,641	-39,825	-31,004	-12,653	-19,474	-17,173	-15,203	-47,851	-9,709	-4,305	0	-33,240	-205,434
Profit After Tax	111,159	89,729	224,415	169,779	132,173	53,941	83,019	68,691	60,812	180,012	32,503	13,631	-67,279	85,474	528,259
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	111,159	89,729	224,415	169,779	132,173	53,941	83,019	68,691	60,812	180,012	32,503	13,631	-67,279	85,474	528,259
Employee Costs	827,398	1,120,802	750,237	619,215	609,301	626,840	727,465	633,309	3,370,725	3,114,692	3,467,909	2,466,893	1,752,442	2,239,930	0
Number Of Employees	32	46	32	27	27	29	34	31	159	145	162	117	84	110	0
EBITDA*	199,337	101,582	307,994	235,631	192,282	94,238	132,713	115,526	108,171	262,270	72,592	33,063	-62,891	124,229	742,420

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	853,110	858,579	835,952	824,815	835,974	732,485	514,405	418,954	419,305	430,365	440,722	392,826	346,829	259,510	270,084
Intangible Assets	6,555	20,339	34,123	38,541	51,388	64,235	77,082	89,929	102,776	115,623	128,470	0	0	0	0
Investments & Other	345,209	232,718	114,946	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	1,204,874	1,111,636	985,021	863,356	887,362	796,720	591,487	508,883	522,081	545,988	569,192	392,826	346,829	259,510	270,084
Stock & work in progress	189,774	164,754	174,061	203,100	162,156	135,887	114,483	117,908	105,743	100,974	82,655	56,112	58,084	67,217	65,783
Trade Debtors	0	0	650,143	428,154	412,408	365,168	190,143	188,226	466,246	389,716	365,811	292,991	222,674	316,258	285,228
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	578,327	584,360	178,466	146,887	113,484	121,587	163,805	137,530	0	0	0	0	0	0	0
Cash	419,353	449,154	368,127	264,996	28,341	20,841	349,461	367,329	130,309	92,878	17,309	103,396	136,311	261,017	201,643
misc current assets	22,055	28,400	20,400	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,209,509	1,226,668	1,391,197	1,043,137	716,389	643,483	817,892	810,993	702,298	583,568	465,775	452,499	417,069	644,492	552,654
total assets	2,414,383	2,338,304	2,376,218	1,906,493	1,603,751	1,440,203	1,409,379	1,319,876	1,224,379	1,129,556	1,034,967	845,325	763,898	904,002	822,738
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	365,135	396,283	571,742	360,219	355,687	338,010	373,724	336,662	355,794	320,359	406,215	259,241	194,590	285,935	290,071
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	228,586	296,662	206,677	176,226	45,446	32,582	13,288	61,255	0	0	0	0	0	0	0
total current liabilities	593,721	692,945	778,419	536,445	401,133	370,592	387,012	397,917	355,794	320,359	406,215	259,241	194,590	285,935	290,071
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	54,244	41,396	32,269	28,933	31,282	30,448	37,145	19,756	15,629	17,053	16,620	6,455	3,310	4,234	4,308
total long term liabilities	54,244	41,396	32,269	28,933	31,282	30,448	37,145	19,756	15,629	17,053	16,620	6,455	3,310	4,234	4,308
total liabilities	647,965	734,341	810,688	565,378	432,415	401,040	424,157	417,673	371,423	337,412	422,835	265,696	197,900	290,169	294,379
net assets	1,766,418	1,603,963	1,565,530	1,341,115	1,171,336	1,039,163	985,222	902,203	852,956	792,144	612,132	579,629	565,998	613,833	528,359
total shareholders funds	1,766,418	1,603,963	1,565,530	1,341,115	1,171,336	1,039,163	985,222	902,203	852,956	792,144	612,132	579,629	565,998	613,833	528,359

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	125,414	101,582	276,739	209,457	162,992	65,205	101,597	85,242	75,457	227,588	41,910	17,336	-68,272	117,557	733,189
Depreciation	60,139	0	17,471	13,327	16,443	16,186	18,269	17,437	19,867	21,835	22,722	15,727	5,381	6,672	9,231
Amortisation	13,784	0	13,784	12,847	12,847	12,847	12,847	12,847	12,847	12,847	7,960	0	0	0	0
Tax	-37,053	-21,048	-52,641	-39,825	-31,004	-12,653	-19,474	-17,173	-15,203	-47,851	-9,709	-4,305	0	-33,240	-205,434
Stock	25,020	-9,307	-29,039	40,944	26,269	21,404	-3,425	12,165	4,769	18,319	26,543	-1,972	-9,133	1,434	65,783
Debtors	-6,033	-244,249	253,568	49,149	39,137	132,807	28,192	-140,490	76,530	23,905	72,820	70,317	-93,584	31,030	285,228
Creditors	-31,148	-175,459	211,523	4,532	17,677	-35,714	37,062	-19,132	35,435	-85,856	146,974	64,651	-91,345	-4,136	290,071
Accruals and Deferred Income	-68,076	89,985	30,451	130,780	12,864	19,294	-47,967	61,255	0	0	0	0	0	0	0
Deferred Taxes & Provisions	12,848	9,127	3,336	-2,349	834	-6,697	17,389	4,127	-1,424	433	10,165	3,145	-924	-74	4,308
Cash flow from operations	56,921	257,743	276,134	238,676	127,247	-95,743	94,956	272,928	45,680	86,772	120,659	28,209	-52,443	54,315	480,354
Investing Activities
capital expenditure	-54,670	-8,843	-37,974	-2,168	-119,932	-234,266	-113,720	-17,086	-8,807	-11,478	-207,048	-61,724	-92,700	3,902	-279,315
Change in Investments	112,491	117,772	114,946	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-167,161	-126,615	-152,920	-2,168	-119,932	-234,266	-113,720	-17,086	-8,807	-11,478	-207,048	-61,724	-92,700	3,902	-279,315
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	51,296	-51,296	0	0	0	0	0	-19,444	0	0	0	0	19,444	0	100
interest	22,798	9,194	317	147	184	1,389	896	622	558	275	302	599	993	1,157	504
cash flow from financing	74,094	-42,102	317	147	184	1,389	896	-18,822	558	275	302	599	20,437	1,157	604
cash and cash equivalents
cash	-29,801	81,027	103,131	236,655	7,500	-328,620	-17,868	237,020	37,431	75,569	-86,087	-32,915	-124,706	59,374	201,643
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-29,801	81,027	103,131	236,655	7,500	-328,620	-17,868	237,020	37,431	75,569	-86,087	-32,915	-124,706	59,374	201,643

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for quayside pharmacy limited. Get real-time insights into quayside pharmacy limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for quayside pharmacy limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in NE1 area or any other competitors across 12 key performance metrics.

QUAYSIDE PHARMACY LIMITED group structure

Quayside Pharmacy Limited has no subsidiary companies.

Ultimate parent company

QUAYSIDE PHARMACY LIMITED

02710642

QUAYSIDE PHARMACY LIMITED Shareholders

mrs sunita jassal	60%
mr arun kumar jassal	40%

Quayside Pharmacy Limited currently has 2 directors. The longest serving directors include Mrs Sunita Jassal (May 1992) and Mr Arun Jassal (Mar 1998).

officer	country	age	start	end	role
Mrs Sunita Jassal	United Kingdom	64 years	May 1992	-	Director
Mr Arun Jassal	United Kingdom	67 years	Mar 1998	-	Director

P&L

September 2023

turnover

2.4m

-19%

operating profit

125.4k

gross margin

38.3%

+2.46%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2023

net assets

1.8m

+0.1%

total assets

2.4m

+0.03%

cash

419.4k

-0.07%

net assets

Total assets minus all liabilities

Similar Companies

ashington central limited

4.5

medical reporting solutions limited

1.5

orbis support limited

2.5

infai u.k. ltd.

3.5

twenty four seven recruitment (yorkshire) limited

3.5

company number

02710642

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

April 1992

ultimate parent company

None

previous names

quayside chemists limited (August 1993)

address

crawhall road, newcastle upon tyne, tyne & wear, NE1 2BL

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to quayside pharmacy limited. Currently there are 0 open charges and 1 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for QUAYSIDE PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.

quayside pharmacy limited Company Information

quayside pharmacy limited Estimated Valuation

quayside pharmacy limited Estimated Valuation

quayside pharmacy limited Estimated Valuation

Quayside Pharmacy Limited Overview

Quayside Pharmacy Limited Health Check

QUAYSIDE PHARMACY LIMITED financials

quayside pharmacy limited Credit Report and Business Information

Quayside Pharmacy Limited Competitor Analysis

quayside pharmacy limited Ownership

quayside pharmacy limited directors

quayside pharmacy limited company details

quayside pharmacy limited Charges & Mortgages

quayside pharmacy limited Capital Raised & Share Issues BETA

quayside pharmacy limited Companies House Filings - See Documents